Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome

Journal of Molecular and Cellular Cardiology

Volumn 85, Issue , 2015, Pages 104-116

  Ilkun, Olesya ^a   Wilde, Nicole ^a   Tuinei, Joseph ^a   Pires, Karla M P ^a   Zhu, Yi ^a,c   Bugger, Heiko ^a,d   Soto, Jamie ^a,b   Wayment, Benjamin ^a   Olsen, Curtis ^a   Litwin, Sheldon E ^a,e   Abel, E Dale ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; DEOXYGLUCOSE; HYDROGEN PEROXIDE; TETRAKIS(4 BENZOIC ACID)PORPHYRIN MANGANESE; UNCLASSIFIED DRUG; FATTY ACID; INSULIN; MANGANESE(III)-TETRAKIS(4-BENZOIC ACID)PORPHYRIN; METALLOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DB/DB MOUSE; FATTY ACID OXIDATION; GLUCOSE INTOLERANCE; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART MITOCHONDRION; HEART VENTRICLE HYPERTROPHY; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC BALANCE; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; MOUSE; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; CARDIAC MUSCLE; ENERGY METABOLISM; HOMEOSTASIS; METABOLISM; MOUSE MUTANT; PRECLINICAL STUDY; SIGNAL TRANSDUCTION;

MUS; RODENTIA;

ANIMALS; ANTIOXIDANTS; DRUG EVALUATION, PRECLINICAL; ENERGY METABOLISM; FATTY ACIDS; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; METALLOPORPHYRINS; MICE, INBRED C57BL; MICE, OBESE; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84930622841     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.05.012     Document Type: Article

References (50)

1. Mente A., Yusuf S., Islam S., McQueen M.J., Tanomsup S., Onen C.L., et al. Metabolic syndrome and risk of acute infarction a case-control study of 26,903 subjects from 52 countries. J Am Coll Cardiol 2010, 55:2390-2398.
2. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
3. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
4. Boudina S., Sena S., O'Neill B.T., Tathireddy P., Young M.E., Abel E.D. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005, 112:2686-2695.
5. Boudina S., Sena S., Theobald H., Sheng X., Wright J.J., Hu X.X., et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007, 56:2457-2466.
6. Kuo T.H., Moore K.H., Giacomelli F., Wiener J. Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. Diabetes 1983, 32:781-787.
7. Bugger H., Chen D., Riehle C., Soto J., Theobald H.A., Hu X.X., et al. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes 2009, 58:1986-1997.
8. Li Y., Wende A.R., Nunthakungwan O., Huang Y., Hu E., Jin H., et al. Cytosolic, but not mitochondrial, oxidative stress is a likely contributor to cardiac hypertrophy resulting from cardiac specific GLUT4 deletion in mice. FEBS J 2012, 279:599-611.
9. Hoehn K.L., Salmon A.B., Hohnen-Behrens C., Turner N., Hoy A.J., Maghzal G.J., et al. Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci U S A 2009, 106:17787-17792.
10. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
11. Duncan J.G., Fong J.L., Medeiros D.M., Finck B.N., Kelly D.P. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptoralpha/ PGC-1alpha gene regulatory pathway. Circulation 2007, 115:909-917.
12. Hamann A., Flier J.S., Lowell B.B. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 1996, 137:21-29.
13. O'Connell K.A., Dabkowski E.R., de Fatima Galvao T., Xu W., Daneault C., de Rosiers C., et al. Dietary saturated fat and docosahexaenoic acid differentially effect cardiac mitochondrial phospholipid fatty acyl composition and Ca(2+) uptake, without altering permeability transition or left ventricular function. Phys Rep 2013, 1:e00009.
14. Galvao T.F., Brown B.H., Hecker P.A., O'Connell K.A., O'Shea K.M., Sabbah H.N., et al. High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc Res 2012, 93:24-32.
15. Chess D.J., Khairallah R.J., O'Shea K.M., Xu W., Stanley W.C. A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload. Am J Physiol Heart Circ Physiol 2009, 297:H1585-H1593.
16. Day B.J., Fridovich I., Crapo J.D. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys 1997, 347:256-262.
17. Day B.J., Shawen S., Liochev S.I., Crapo J.D. A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro. J Pharmacol Exp Ther 1995, 275:1227-1232.
18. Boudina S., Bugger H., Sena S., O'Neill B.T., Zaha V.G., Ilkun O., et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 2009, 119:1272-1283.
19. Schneider B.D., Leibold E.A. Effects of iron regulatory protein regulation on iron homeostasis during hypoxia. Blood 2003, 102:3404-3411.
20. Kim J., Wende A.R., Sena S., Theobald H.A., Soto J., Sloan C., et al. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol 2008, 22:2531-2543.
21. Bugger H., Riehle C., Jaishy B., Wende A.R., Tuinei J., Chen D., et al. Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. J Mol Cell Cardiol 2012, 52:1019-1026.
22. Mazumder P.K., O'Neill B.T., Roberts M.W., Buchanan J., Yun U.J., Cooksey R.C., et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004, 53:2366-2374.
23. O'Neill B.T., Kim J., Wende A.R., Theobald H.A., Tuinei J., Buchanan J., et al. A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab 2007, 6:294-306.
24. Riehle C., Wende A.R., Sena S., Pires K.M., Pereira R.O., Zhu Y., et al. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. J Clin Invest 2013, 123:5319-5333.
25. Belke D.D., Betuing S., Tuttle M.J., Graveleau C., Young M.E., Pham M., et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002, 109:629-639.
26. Frayn K.N., Maycock P.F. Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res 1980, 21:139-144.
27. Wende A.R., Soto J., Olsen C.D., Pires K.M., Schell J.C., Larrieu-Lahargue F., et al. Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice. Endocrinology 2010, 151:3536-3542.
28. Mandarim-de-Lacerda C.A. Stereological tools in biomedical research. An Acad Bras Cienc 2003, 75:469-486.
29. Sena S., Rasmussen I.R., Wende A.R., McQueen A.P., Theobald H.A., Wilde N., et al. Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology 2007, 148:6047-6053.
30. Lowell B.B., S-Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
31. Niemann B., Chen Y., Teschner M., Li L., Silber R.E., Rohrbach S. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol 2011, 57:577-585.
32. Shen X., Zheng S., Metreveli N.S., Epstein P.N. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 2006, 55:798-805.
33. Ye G., Metreveli N.S., Donthi R.V., Xia S., Xu M., Carlson E.C., et al. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004, 53:1336-1343.
34. Boudina S., Sena S., Sloan C., Tebbi A., Han Y.H., O'Neill B.T., et al. Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin sensitivity. Endocrinology 2012, 153:2677-2688.
35. Pires K.M., Ilkun O., Valente M., Boudina S. Treatment with a SOD mimetic reduces visceral adiposity, adipocyte death, and adipose tissue inflammation in high fat-fed mice. Obesity 2014, 22:178-187.
36. Bashan N., Kovsan J., Kachko I., Ovadia H., Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 2009, 89:27-71.
37. Chiarugi P., Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 2003, 28:509-514.
38. Dai D.F., Chen T., Szeto H., Nieves-Cintron M., Kutyavin V., Santana L.F., et al. Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 2011, 58:73-82.
39. Dai D.F., Johnson S.C., Villarin J.J., Chin M.T., Nieves-Cintron M., Chen T., et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res 2011, 108:837-846.
40. Takimoto E., Kass D.A. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007, 49:241-248.
41. St-Pierre J., Buckingham J.A., Roebuck S.J., Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 2002, 277:44784-44790.
42. Danielson S.R., Held J.M., Oo M., Riley R., Gibson B.W., Andersen J.K. Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model. J Biol Chem 2011, 286:7601-7608.
43. Lefort N., Glancy B., Bowen B., Willis W.T., Bailowitz Z., De Filippis E.A., et al. Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 2010, 59:2444-2452.
44. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
45. Wang C.H., Wang C.C., Wei Y.H. Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann N Y Acad Sci 2010, 1201:157-165.
46. Huang S., Czech M.P. The GLUT4 glucose transporter. Cell Metab 2007, 5:237-252.
47. Larance M., Ramm G., James D.E. The GLUT4 code. Mol Endocrinol 2008, 22:226-233.
48. Sloan C., Tuinei J., Nemetz K., Frandsen J., Soto J., Wride N., et al. Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice. Diabetes 2011, 60:1424-1434.
49. Wright J.J., Kim J., Buchanan J., Boudina S., Sena S., Bakirtzi K., et al. Mechanisms for ncreased myocardial fatty acid utilization following short-term high-fat feeding. Cardiovasc Res 2009, 82:351-360.
50. Zhu Y., Pereira R.O., O'Neill B.T., Riehle C., Ilkun O., Wende A.R., et al. Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation. Mol Endocrinol 2013, 27:172-184.